AI Revolutionizing Clinical and Molecular Diagnostics

In a groundbreaking development, the market for AI in clinical and molecular diagnostics is set to experience a phenomenal growth trajectory, projected to skyrocket from USD 2.6 billion in 2024 to USD 8.9 billion by 2029 with a robust CAGR of 27.6%.